Advertisement

Lipid Management with Statins/Ezetimibe Proposed for Chronic Kidney Disease — Physician’s First Watch

Medical News |
December 10, 2013

Lipid Management with Statins/Ezetimibe Proposed for Chronic Kidney Disease

By Joe Elia

The Kidney Disease: Improving Global Outcomes (KDIGO) group is recommending that patients with chronic kidney disease receive lipid management with either statins alone or with ezetimibe. The guideline appears in the Annals of Internal Medicine.

The group, which has industry ties, makes 13 recommendations. The key one is that all patients aged 50 or above with an estimated glomerular filtration rate under 60 mL/min should receive a statin or statin/ezetimibe treatment unless they are on dialysis or have received a kidney transplant.

Asked to comment, cardiologist Harlan Krumholz of NEJM Journal Watch wrote: "The international guidelines follow the lead of the U.S. guidelines by abandoning treat-to-target, strengthening the movement to funnel discussions about treatment toward risk reduction and away from chasing treatment targets."

Reader Comments (2)

Arnold EINHORN MD Physician, Pediatrics/Adolescent Medicine

I am intrigued by Dr Krumholz comment. Does he agree or not with the KIDIGO recommendation?

HARLAN KRUMHOLZ Physician, Cardiology, Yale

Worth noting that this guideline was written by an industry-sponsored, self-appointed group - and the recommendation is industry friendly.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement